Literature DB >> 18347568

Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.

H J Lee, A Gulbis, L De Padua Silva, C Hosing, I Khouri, M de Lima, R E Champlin, S O Ciurea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18347568      PMCID： PMC7184767          DOI： 10.1038/bmt.2008.79

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation.

Authors:  A Ship; W May; K Lucas
Journal:  Bone Marrow Transplant       Date:  2002-02       Impact factor: 5.483

2.  Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation.

Authors:  P Corti; S Bonanomi; C Vallinoto; A Balduzzi; C Uderzo; G Cazzaniga; G Gaipa; M Dassi; P Perseghin; A Rovelli
Journal:  Acta Haematol       Date:  2003       Impact factor: 2.195

3.  Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.

Authors:  J Hows; K Beddow; E Gordon-Smith; D R Branch; W Spruce; I Sniecinski; R A Krance; L D Petz
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

4.  Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.

Authors:  J L Gajewski; L D Petz; L Calhoun; S O'Rourke; E M Landaw; N R Lyddane; L A Hunt; G J Schiller; W G Ho; R E Champlin
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

5.  Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation.

Authors:  A Toren; Y Dacosta; N Manny; G Varadi; R Or; A Nagler
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

6.  Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.

Authors:  B Horn; M Viele; W Mentzer; N Mogck; K DeSantes; M Cowan
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

7.  Posttransplant immune-mediated hemolysis.

Authors:  Robert J Sokol; Robert Stamps; David J Booker; Fiona M Scott; Stuart T Laidlaw; Elisabeth A Vandenberghe; Helen F Barker
Journal:  Transfusion       Date:  2002-02       Impact factor: 3.157

8.  Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.

Authors:  M de Lima; R E Champlin; P F Thall; X Wang; T G Martin; J D Cook; G McCormick; M Qazilbash; P Kebriaei; D Couriel; E J Shpall; I Khouri; P Anderlini; C Hosing; K W Chan; B S Andersson; P A Patah; Z Caldera; E Jabbour; S Giralt
Journal:  Leukemia       Date:  2007-11-08       Impact factor: 11.528

9.  Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant.

Authors:  F Panaro; P J DeChristopher; D Rondelli; G Testa; H Sankary; M Popescu; E Benedetti
Journal:  Clin Transplant       Date:  2004-06       Impact factor: 2.863

Review 10.  Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.

Authors:  Mark H Yazer; Darrell J Triulzi
Journal:  Curr Opin Hematol       Date:  2007-11       Impact factor: 3.284
  10 in total
  9 in total

1.  Passenger Lymphocyte Syndrome and Autoimmune Hypothyroidism Following Hematopoietic Stem Cell Transplantation.

Authors:  Denis F Noubouossie; Mohammed I A Zaanona; Luciano J Costa; Huy P Pham; Marisa B Marques; Antonio Di Stasi
Journal:  Case Reports Immunol       Date:  2022-06-23

2.  ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations.

Authors:  Judith S Hecker; Adam Wahida; Erik Hameister; Aneta Filo; Jürgen Ruland; Florian Bassermann; Martin Hildebrandt; Mareike Verbeek; Hendrik Poeck
Journal:  EJHaem       Date:  2021-03-24

Review 3.  A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.

Authors:  James L Gajewski; Viviana V Johnson; S Gerald Sandler; Antoine Sayegh; Thomas R Klumpp
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

Review 4.  Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases.

Authors:  Samuel Romero; Pilar Solves; Aima Lancharro; Isabel Cano; Federico Moscardó; Nelly Carpio; Miguel Á Sanz
Journal:  Blood Transfus       Date:  2015-04-28       Impact factor: 3.443

5.  IgM anti-recipient ABO antibodies predict acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Authors:  Yoshitaka Zaimoku; Akiyoshi Takami; Hidehiro Sato; Maki Utsumi; Shinji Nakao
Journal:  Int J Hematol       Date:  2013-05-10       Impact factor: 2.490

6.  Passenger lymphocyte syndrome: a forgotten cause of postliver transplant jaundice and anemia.

Authors:  Joshua R Peck; Elmahdi A Elkhammas; Feng Li; Peter P Stanich; Nicholas Latchana; Sylvester Black; Anthony Michaels
Journal:  Exp Clin Transplant       Date:  2014-07-31       Impact factor: 0.945

7.  Passenger Lymphocyte Syndrome (PLS): A Single-center Retrospective Analysis of Minor ABO-incompatible Liver Transplants.

Authors:  Sévérine de Bruijn; Ester Philipse; Marie Madeleine Couttenye; Bart Bracke; Dirk Ysebaert; Peter Michielsen; Sven Francque; Thomas Vanwolleghem; Anke Verlinden
Journal:  J Clin Transl Hepatol       Date:  2017-03-20

8.  Passenger Lymphocyte Syndrome as a rare cause of hemolysis in a patient after small intestine transplantation, A case report and review of the literature.

Authors:  Edalat Zarei; Mojtaba Shafiekhani; Nazanin Azadeh; Alireza Shamsaeefar; Mahnaz Lotfi; Mahbube Ahrami; Amirhassan Rabbani; Hamed Nikoupour
Journal:  Asian J Transfus Sci       Date:  2022-05-26

Review 9.  Passenger lymphocyte syndrome and liver transplantation.

Authors:  Maxime Audet; Fabrizio Panaro; Tullio Piardi; Ping Huang; Murat Cag; Jacques Cinqualbre; Philippe Wolf
Journal:  Clin Dev Immunol       Date:  2009-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.